Monday, May 28, 2012

The Going Concern Warning in the KV Pharma 10-K

"Our future business success in the next several years, as well as the continuing operation of our Company, depends critically upon our successful market launch of Makena® and our ability to achieve revenues from the sale of Makena® consistent with our business expectations. A failure to achieve these objectives and sufficient market success in selling Makena® will materially adversely affect the success and viability of our Company and would likely result in a default under our debt obligations."

No comments: